Half Yearly Report

RNS Number : 5754B

Dechra Pharmaceuticals PLC

05 March 2014

 

Date: Wednesday, 5 March 2014

Dechra^® Pharmaceuticals PLC

(the "Company")

Half-Yearly Report

for the six months ended 31 December 2013

The Company announced its Half-Yearly Results for the period ended 31 December 2013 on 25 February 2014.  The Half-Yearly Report has now been posted to Shareholders and a copy has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

The Half-Yearly Report is also available to view on the Company's website www.dechra.com.  Further copies of the Half-Yearly Report are available from the Company's registered office at:

24 Cheshire Avenue

Cheshire Business Park

Lostock Gralam

Northwich

CW9 7UA

Enquiries:

Zoe Goulding, Company Secretary

Dechra Pharmaceuticals PLC

Tel: [phone]

E-mail: [e-mail]

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide.  Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com.

Stock Code: Full Listing (Pharmaceuticals): DPH

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

ACSLLFLIVTIEIIS